Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Reconstituted with 3.0 mL BAC water, the maximum fill used for this vial math
Wegovy (Injection) Adults and children age 12 and older with obesity (a body mass index, or BMI, of 30 or higher) Adults and children age 12 and older who are overweight (a BMI of 27 or higher) and have at least one weight-related condition, such as high blood pressure, high cholesterol or triglycerides, or type 2 diabetes Wegovy (Pill) Adults with obesity Adults who are overweight and have at least one weight-related comorbid condition Adults with established heart disease who either have obesity or are overweight Zepbound Adults with obesity Adults who are overweight and have at least one weight-related condition Dosage Weight Loss Other Benefits Beyond weight loss, both medications offer additional health benefits, says Dr
One emerging treatment we are monitoring is the use of tirzepatide for weight loss in non-diabetic individuals
Unlike the DAC version, it mimics the body's natural hormone cycles, which helps reduce the risk of receptor fatigue and long-term complications
Goldman Sachs estimated the injectable drug market for weight loss to reach at least $100B by 2030, and they are far from the only ones to have noticed it
